2021中国静脉血栓栓塞症防治抗凝药物的选用与药学监护指南

2021-11-21 首都医科大学附属北京天坛医院药学部 中国临床药理学杂志

静脉血栓栓塞症近年来越来越引起医学界的广泛关注。本指南依照世界 卫生组织( WHO) 指南制作标准进行制定,证据与推荐意见的评价方法用评估建 议的评级、发展和评价( GRADE) 分级。

中文标题:

2021中国静脉血栓栓塞症防治抗凝药物的选用与药学监护指南

发布日期:

2021-11-21

简要介绍:

静脉血栓栓塞症近年来越来越引起医学界的广泛关注。本指南依照世界 卫生组织( WHO) 指南制作标准进行制定,证据与推荐意见的评价方法用评估建 议的评级、发展和评价( GRADE) 分级。为更好地指导我国医师、药师的临床实 践,本指南系统评价了深静脉血栓防治中抗凝药物使用中的循证证据,针对不同 科室抗凝药物的选用和药学监护、抗凝药物过量的处理等共计 30 个临床问题, 从药师的角度给出推荐意见,进一步规范我国静脉血栓栓塞防治中抗凝药物的合理使用。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=_2021中国静脉血栓栓塞症防治抗凝药物的选用与药学监护指南.pdf)] GetToolGuiderByIdResponse(projectId=1, id=252611c0022e529c, title=2021中国静脉血栓栓塞症防治抗凝药物的选用与药学监护指南, enTitle=, guiderFrom=中国临床药理学杂志, authorId=0, author=, summary=静脉血栓栓塞症近年来越来越引起医学界的广泛关注。本指南依照世界 卫生组织( WHO) 指南制作标准进行制定,证据与推荐意见的评价方法用评估建 议的评级、发展和评价( GRADE) 分级。, cover=https://img.medsci.cn/20211129/1638155237420_5579292.png, journalId=0, articlesId=null, associationId=2159, associationName=首都医科大学附属北京天坛医院药学部, associationIntro=首都医科大学附属北京天坛医院药学部, copyright=0, guiderPublishedTime=Sun Nov 21 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="page" title="Page 1"> <div class="layoutArea"> <div class="column"> <p>静脉血栓栓塞症近年来越来越引起医学界的广泛关注。本指南依照世界 卫生组织( WHO) 指南制作标准进行制定,证据与推荐意见的评价方法用评估建 议的评级、发展和评价( GRADE) 分级。为更好地指导我国医师、药师的临床实 践,本指南系统评价了深静脉血栓防治中抗凝药物使用中的循证证据,针对不同 科室抗凝药物的选用和药学监护、抗凝药物过量的处理等共计 30 个临床问题, 从药师的角度给出推荐意见,进一步规范我国静脉血栓栓塞防治中抗凝药物的合理使用。</p> <p>&nbsp;</p> </div> </div> </div>, tagList=[TagDto(tagId=57456, tagName=静脉血栓栓塞症), TagDto(tagId=117835, tagName=静脉系统疾病)], categoryList=[CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=92, categoryName=血管外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=57456, guiderKeyword=静脉血栓栓塞症, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6113, appHits=830, showAppHits=0, pcHits=1540, showPcHits=5283, likes=7, shares=105, comments=32, approvalStatus=1, publishedTime=Mon Nov 29 11:40:44 CST 2021, publishedTimeString=2021-11-21, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=FUNNYMAN, createdTime=Mon Nov 29 11:07:14 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 22:13:31 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=_2021中国静脉血栓栓塞症防治抗凝药物的选用与药学监护指南.pdf)])
_2021中国静脉血栓栓塞症防治抗凝药物的选用与药学监护指南.pdf
下载请点击:
评论区 (25)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1214931, encodeId=7112121493173, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Wed Apr 27 06:35:26 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199440, encodeId=b4bc11994407d, content=无法下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a6d6534121, createdName=ms3000000452816472, createdTime=Fri Mar 04 17:41:34 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194642, encodeId=55d711946426d, content=下载不了看不了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1076466407, createdName=ms9000001994529014, createdTime=Fri Feb 18 00:25:42 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186688, encodeId=fd8d11866886a, content=什么玩意儿!积分没了,指南没有!耍大刀呢👿💩, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/01/8e66740682bddc0261057ded2f1c0105.jpg, createdBy=70387980, createdName=songlisw, createdTime=Fri Jan 21 08:00:34 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180361, encodeId=ab3b118036143, content=怎么下载不了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210129/bdf7258720c047eaa33e0e2b57d79b93/59ab62b3fd784cc2a9f41efcaf164b23.jpg, createdBy=cac42270752, createdName=121a4306m63暂无昵称, createdTime=Tue Jan 04 11:41:17 CST 2022, time=2022-01-04, status=1, ipAttribution=)]
    2022-04-27 su_yi_fei

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1214931, encodeId=7112121493173, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Wed Apr 27 06:35:26 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199440, encodeId=b4bc11994407d, content=无法下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a6d6534121, createdName=ms3000000452816472, createdTime=Fri Mar 04 17:41:34 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194642, encodeId=55d711946426d, content=下载不了看不了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1076466407, createdName=ms9000001994529014, createdTime=Fri Feb 18 00:25:42 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186688, encodeId=fd8d11866886a, content=什么玩意儿!积分没了,指南没有!耍大刀呢👿💩, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/01/8e66740682bddc0261057ded2f1c0105.jpg, createdBy=70387980, createdName=songlisw, createdTime=Fri Jan 21 08:00:34 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180361, encodeId=ab3b118036143, content=怎么下载不了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210129/bdf7258720c047eaa33e0e2b57d79b93/59ab62b3fd784cc2a9f41efcaf164b23.jpg, createdBy=cac42270752, createdName=121a4306m63暂无昵称, createdTime=Tue Jan 04 11:41:17 CST 2022, time=2022-01-04, status=1, ipAttribution=)]
    2022-03-04 ms3000000452816472

    无法下载

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1214931, encodeId=7112121493173, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Wed Apr 27 06:35:26 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199440, encodeId=b4bc11994407d, content=无法下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a6d6534121, createdName=ms3000000452816472, createdTime=Fri Mar 04 17:41:34 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194642, encodeId=55d711946426d, content=下载不了看不了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1076466407, createdName=ms9000001994529014, createdTime=Fri Feb 18 00:25:42 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186688, encodeId=fd8d11866886a, content=什么玩意儿!积分没了,指南没有!耍大刀呢👿💩, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/01/8e66740682bddc0261057ded2f1c0105.jpg, createdBy=70387980, createdName=songlisw, createdTime=Fri Jan 21 08:00:34 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180361, encodeId=ab3b118036143, content=怎么下载不了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210129/bdf7258720c047eaa33e0e2b57d79b93/59ab62b3fd784cc2a9f41efcaf164b23.jpg, createdBy=cac42270752, createdName=121a4306m63暂无昵称, createdTime=Tue Jan 04 11:41:17 CST 2022, time=2022-01-04, status=1, ipAttribution=)]
    2022-02-18 ms9000001994529014

    下载不了看不了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1214931, encodeId=7112121493173, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Wed Apr 27 06:35:26 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199440, encodeId=b4bc11994407d, content=无法下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a6d6534121, createdName=ms3000000452816472, createdTime=Fri Mar 04 17:41:34 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194642, encodeId=55d711946426d, content=下载不了看不了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1076466407, createdName=ms9000001994529014, createdTime=Fri Feb 18 00:25:42 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186688, encodeId=fd8d11866886a, content=什么玩意儿!积分没了,指南没有!耍大刀呢👿💩, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/01/8e66740682bddc0261057ded2f1c0105.jpg, createdBy=70387980, createdName=songlisw, createdTime=Fri Jan 21 08:00:34 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180361, encodeId=ab3b118036143, content=怎么下载不了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210129/bdf7258720c047eaa33e0e2b57d79b93/59ab62b3fd784cc2a9f41efcaf164b23.jpg, createdBy=cac42270752, createdName=121a4306m63暂无昵称, createdTime=Tue Jan 04 11:41:17 CST 2022, time=2022-01-04, status=1, ipAttribution=)]
    2022-01-21 songlisw

    什么玩意儿!积分没了,指南没有!耍大刀呢👿💩

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1214931, encodeId=7112121493173, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Wed Apr 27 06:35:26 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199440, encodeId=b4bc11994407d, content=无法下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a6d6534121, createdName=ms3000000452816472, createdTime=Fri Mar 04 17:41:34 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194642, encodeId=55d711946426d, content=下载不了看不了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1076466407, createdName=ms9000001994529014, createdTime=Fri Feb 18 00:25:42 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186688, encodeId=fd8d11866886a, content=什么玩意儿!积分没了,指南没有!耍大刀呢👿💩, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/01/8e66740682bddc0261057ded2f1c0105.jpg, createdBy=70387980, createdName=songlisw, createdTime=Fri Jan 21 08:00:34 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180361, encodeId=ab3b118036143, content=怎么下载不了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210129/bdf7258720c047eaa33e0e2b57d79b93/59ab62b3fd784cc2a9f41efcaf164b23.jpg, createdBy=cac42270752, createdName=121a4306m63暂无昵称, createdTime=Tue Jan 04 11:41:17 CST 2022, time=2022-01-04, status=1, ipAttribution=)]
    2022-01-04 121a4306m63暂无昵称

    怎么下载不了

    0

拓展阅读

静脉血栓栓塞症抗凝治疗微循环血栓防治专家共识

中国微循环学会(CMS,Chinese Society of Microcirculation) 周围血管疾病专业委员会 静脉血栓栓塞症抗凝治疗微循环血栓防治共识专家组 · 2017-04-28

梯度压力袜用于静脉血栓栓塞症防治专家共识

国际血管联盟(IUA,International Union of Angiology) · 2019-09-30

2021ASH 静脉血栓栓塞症管理指南:癌症患者的预防和治疗

美国血液病学会(ASH,American Society of Hematology) · 2021-02-23

中国减重与代谢外科围手术期静脉血栓栓塞症预防指南(2021版)

国家卫生健康委员会能力建设和继续教育外科学专家委员会减重与代谢外科专业委员会 · 2022-01-01

普通外科患者静脉血栓栓塞症风险评估与预防护理专家共识

中华护理学会外科护理专业委员会 · 2022-02-20